Gara Jalqabaatti › Baayyee Ulfaataa › Louisiana › Baton Rouge
Qorannoo klinikaalii Baayyee Ulfaataa Baton Rouge, LA keessatti
Qorannoo 10 Baayyee Ulfaataa f Baton Rouge fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Velocity Clinical Research - Baton Rouge, Baton Rouge
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Namoota walitti qabaa jiraSadarkaa 3
- Pennington Biomed Res Ctr, Baton Rouge
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Pennington Biomedical Research Center, Baton Rouge
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Namoota walitti qabaa jiraSadarkaa 3
- Southern Clin Research, Zachary · Miili 14 fagaatti
Impact of Lean Pork on Endothelial Function in Perimenopause
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Pennington Biomedical Research Center, Baton Rouge
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-2 Clinical Site, Baton Rouge
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-1 Clinical Site, Baton Rouge
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Namoota walitti qabaa jiraSadarkaa 3
- Pennington Biomedical Research Center, Baton Rouge
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Namoota walitti qabaa jiraSadarkaa 3
- ACCOMPLISH-1 Research Site, Baton Rouge
Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Pennington Biomedical Research Center, Baton Rouge
Qorannoo Baayyee Ulfaataa magaalota biroo keessatti
- San Antonio, TXQorannoo 34
- Houston, TXQorannoo 33
- Chicago, ILQorannoo 29
- Orlando, FLQorannoo 27
- Las Vegas, NVQorannoo 23
- Miami, FLQorannoo 23
- Dallas, TXQorannoo 20
- Atlanta, GAQorannoo 20
- New York City, NYQorannoo 19
- Jacksonville, FLQorannoo 19
- Washington, DCQorannoo 19
- Austin, TXQorannoo 18
Qorannoo biroo Baton Rouge keessatti
- ObesityQorannoo 15
- Kansara Qara'a Non-Small CellQorannoo 10
- Kansara MetastatikiiQorannoo 9
- Leukemia Myeloidii HamaaQorannoo 8
- Dhibee QaraQorannoo 8
- Kansarii ColorectalQorannoo 8
- Saree OljooQorannoo 7
- Dukkana BladderQorannoo 6
- Luukemiya Limfoositiikii KeessummaaQorannoo 5
- Kansarii ProstateQorannoo 5
- COPDQorannoo 5
- Cufama OnneeQorannoo 5
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.